The Role of Skin Vaccination and Stock Piling to prevent vaccine shortages

Vaccine Shortages: Millions of children worldwide miss out on vaccines due to shortages and supply chain problems (1). The COVID-19 and Mpox emergencies exposed weaknesses in global vaccine purchasing, stockpiling and distribution systems (2). Skin Vaccination and stock piling can help to achieve this goal.

Innovative Solutions to address shortages and stockouts : 

• Skin (intradermal) Vaccination:
  Uses only 20% of the normal vaccine dose (3), allowing more people to be vaccinated with the same supply. Using smaller quantities of vaccine also reduces the need for extensive storage and transportation, resulting in significant savings on refrigeration, warehousing, and logistics.
  This method was approved by several health authorities during the Mpox outbreak (4)
• Stockpiling Strategies:
  The combination of a real minimal stock and a virtual, convertible stock could ensure quick access to medical devices and vaccines during emergencies.

Our white paper “Optimising Vaccine Supply Chain, Stockpiling and Procurement Efficiencies to overcome Shortages and Stockouts – Skin Vaccination to the rescue” reveals why VAX-ID’s intradermal vaccination technology has the potential to enhance the efficiency and effectiveness of vaccination programs.

VAX-ID a game-changing device for skin (intradermal) vaccination

• Reduces the amount of vaccine needed (dose-sparing)
• Lowers storage and transport cost
• Minimizes vaccine waste
• Makes it easier to reach remote areas
• Has a long shelf life (5 years), making it ideal for stockpiling.